Recombinant multi-species YY1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine YY1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
YY1 is a ubiquitously distributed transcription factor belonging to the GLI-Kruppel class of zinc finger proteins. The protein is involved in repressing and activating a diverse number of promoters. YY1 may direct histone deacetylases and histone acetyltransferases to a promoter in order to activate or repress the promoter, thus implicating histone modification in the function of YY1. [provided by RefSeq, Jul 2008]
The Alternative Names of target: DELTA,Delta transcription factor,GADEVS,INO80 complex subunit S,INO80S,NF-E1,NMP-1,NMP1,Transcriptional repressor protein YY1,UCRBP,YIN-YANG-1,YY-1,YY1,Yin and yang 1 (YY-1),Yy1

Target products collectionGo to YY1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP11937-Ag-1/ GM-Tg-hg-IP11937-Ag-2 Human YY1 protein Human
GM-Tg-rg-IP11937-Ag-1/ GM-Tg-rg-IP11937-Ag-2 Rat YY1 protein Rat
GM-Tg-mg-IP11937-Ag-1/ GM-Tg-mg-IP11937-Ag-2 Mouse YY1 protein Mouse
GM-Tg-cynog-IP11937-Ag-1/ GM-Tg-cynog-IP11937-Ag-2 Cynomolgus/Rhesus macaque YY1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP11937-Ag-1/ GM-Tg-felg-IP11937-Ag-2 Feline YY1 protein Feline
GM-Tg-cang-IP11937-Ag-1/ GM-Tg-cang-IP11937-Ag-2 Canine YY1 protein Canine
GM-Tg-bovg-IP11937-Ag-1/ GM-Tg-bovg-IP11937-Ag-2 Bovine YY1 protein Bovine
GM-Tg-equg-IP11937-Ag-1/ GM-Tg-equg-IP11937-Ag-2 Equine YY1 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP11937-Ag-1/ GM-Tg-hg-IP11937-Ag-2; GM-Tg-rg-IP11937-Ag-1/ GM-Tg-rg-IP11937-Ag-2;
GM-Tg-mg-IP11937-Ag-1/ GM-Tg-mg-IP11937-Ag-2; GM-Tg-cynog-IP11937-Ag-1/ GM-Tg-cynog-IP11937-Ag-2;
GM-Tg-felg-IP11937-Ag-1/ GM-Tg-felg-IP11937-Ag-2; GM-Tg-cang-IP11937-Ag-1/ GM-Tg-cang-IP11937-Ag-2;
GM-Tg-bovg-IP11937-Ag-1/ GM-Tg-bovg-IP11937-Ag-2; GM-Tg-equg-IP11937-Ag-1/ GM-Tg-equg-IP11937-Ag-2
Products Name YY1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name YY1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine YY1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.